A primary role of GSTs (glutathione transferases) is detoxication of electrophilic compounds. In addition to this protective function, hGST (human GST) A3-3, a member of the Alpha class of soluble GSTs, has prominent steroid double-bond isomerase activity. The isomerase reaction is an obligatory step in the biosynthesis of steroid hormones, indicating a special role of hGST A3-3 in steroidogenic tissues. An analogous GST with high steroid isomerase activity has so far not been found in any other biological species. In the present study, we characterized a Sus scrofa (pig) enzyme, pGST A2-2, displaying high steroid isomerase activity. High levels of pGST A2-2 expression were found in ovary, testis and liver. In its functional properties, other than steroid isomerization, pGST A2-2 was most similar to hGST A3-3. The properties of the novel porcine enzyme lend support to the notion that particular GSTs play an important role in steroidogenesis.
INTRODUCTION
GSTs (glutathione transferases) (EC 2.5.1.18) of mammals are detoxication enzymes that catalyse the conjugation of the ubiquitous tripeptide glutathione (γ -Glu-Cys-Gly) to exogenous and endogenous electrophiles [1] [2] [3] [4] [5] reacting with DNA, RNA, proteins and other essential cell components with exposed nucleophilic centres. GSTs of the Alpha, Mu and Pi classes have alternative non-enzymatic functions as ligandins [6] [7] [8] [9] and modulators of the activity of the kinases involved in cellular signalling [10] [11] [12] . A unique feature of Alpha class GSTs is steroid isomerase activity, where GSH is used as a cofactor rather than as a substrate [13] as in conjugation reactions.
Steroid hormones (mineralocorticoids, glucocorticoids, oestrogens, androgens and progestagens) play crucial roles in homoeostasis and development in humans. Biosynthesis of steroid hormones begins with the cleavage of the cholesterol side chain and proceeds through a series of reactions dependent on pyridine nucleotides [14, 15] . Oxidation of the 3β-OH group in the steroid scaffold is followed by 5 → 4 double bond migration. Both of these steps are indispensable in the production of all types of steroid hormones. Although early enzymatic studies suggested the presence of two or three pathway-specific double-bond isomerases (mentioned in [15] ), it has been widely accepted that both oxidation and isomerization are catalysed in tandem by a single enzyme 3β-HSD (3β-hydroxysteroid dehydrogenase) [16] . However, it has since been found that the most efficient in vitro catalyst of the double-bond isomerization in 5PD ( 5 -pregnene-3,20-dione) and 5AD ( 5 -androstene-3,17-dione) is a human Alpha class GST, hGST (human GST) A3-3 [17] . The corresponding mRNA has been detected in all classical steroidogenic tissues such as adrenal gland, mammary gland, gonads and placenta, as well as in trachea, lung and stomach, but it has not been found in thymus, liver, skeletal muscle or fetal brain [17, 18] . It has also been estimated that 74 % of the steroid isomerase activity with 5AD is GSHdependent in the human adrenocortical cell line H295R, and 10-30 % of the isomerization leading to progesterone in the placental choriocarcinoma cell line JEG3 is catalysed by hGST A3-3 [19] . Hence hGST A3-3 has been suggested to complement the activity of 3β-HSD isomerase in vivo.
The aim of present study was to investigate the presence of GSTs with high steroid isomerase activity in other eutherian species. The pig (Sus scrofa) is used as an animal model for humans in studies of, among other things, the reproductive system owing to physiological similarities between the two species [20] . Also, pig reproduction is being investigated because pigs remain one of the most important food sources. Many efforts have been put into breeding of sows with high reproduction efficiency and improved fertility traits [21] . Besides, steroid production is known to influence pork meat quality [22] . Thus as complete as possible a knowledge of the steroidogenic pathways in pigs is desirable. In addition, the presence of an analogous enzyme in another mammalian species would support the notion of a significant function of hGST A3-3 in humans. In the present study, we addressed the question of whether there were GSTs in the pig that would possess significant steroid isomerase activity and act as analogues of hGST A3-3.
EXPERIMENTAL

Isolation of total RNA
Ovary and testis specimens from the domesticated Large White pig intercrossed with European Wild Boar were kindly provided by Emmanuelle Bourneuf and Leif Andersson (Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden). Total RNA was isolated from the tissues Abbreviations used: 5AD, 5 -androstene-3,17-dione; AMV, avian myeloblastosis virus; CDNB, 1-chloro-2,4-dinitrobenzene; CHP, cumene hydroperoxide; EA, ethacrynic acid; GST, glutathione transferase; bGST, bovine GST; hGST, human GST; pGST, porcine GST; Hex, trans-hex-2-enal; 3β-HSD, 3β-hydroxysteroid dehydrogenase; Non, trans-non-2-enal; 5PD, 5 -pregnene-3,20-dione; PEITC, phenethyl isothiocyanate. 1 To whom correspondence should be addressed (email Bengt.Mannervik@biorg.uu.se).
using the RNeasy Mini kit (Qiagen), its quantity and purity were assessed spectrophotometrically, and the RNA integrity was verified by denaturing electrophoresis of 4 μg of RNA according to the manufacturer's instructions.
cDNA synthesis
A 2 μg amount of total RNA was incubated with 1 unit of DNase I (Sigma) in a 10 μl volume at 22
• C for 15 min and the DNase I was inactivated by the addition of Stop Solution (Sigma) followed by heating at 70
• C for 10 min and chilling on ice. The mixture was supplemented with anchored oligo(dT) 23 primers (Sigma) to a final concentration of 3.5 μM, heated at 70
• C for 10 min and chilled on ice. Then, 2 μl of 10 × AMV (avian myeloblastosis virus) reverse transcriptase buffer (Sigma), 40 units of RNase inhibitor (Sigma), 2 μl of 10 mM dNTPs solution (Sigma) and 20 units of AMV reverse transcriptase (Sigma) were added to a final volume of 20 μl and incubated at 50
• C for 1 h. The reaction was stopped by heating at 85
• C for 5 min, and mixtures were stored at −20
• C for subsequent pGST (porcine GST) A2 amplification by PCR.
Amplification of nucleotide sequence coding pGSTA2
Primers for PCR amplification were 5 -TTTTTTGGATCC-ATATGGCGGGGAAGCCCATTCTTC-3 and 5 -TTTTTTA-AGCTTATTTAAACTTGAAAATCCTCC-3 (Thermo Electron). The reaction mixture (50 μl) included 2 μl of cDNA, 1 × Phusion HF buffer (Finnzymes), 0.2 mM dNTPs (Sigma), 0.5 μM of each primer and 1 unit of Phusion DNA polymerase (Finnzymes). Reaction mixtures were heated for 3 min at 98
• C, followed by 35 cycles of 98
• C for 1 min, 62
• C for 1 min, 72
• C for 1 min and, finally, by an additional 10 min at 72
• C. PCR products were separated on a 1.2% agarose/TAE (Tris/acetate/EDTA) gel and stained with ethidium bromide. A fragment of 696 bp was isolated from the gel using a QIAquick Gel Extraction kit (Qiagen), and stored at −20
• C.
Construction of the cloning plasmid pGEM-3Zf(+)-pGSTA2
The amplified pGSTA2 cDNA was digested with BamHI and HindIII, yielding a 682 bp fragment that, after electrophoresis, was purified using a QIAquick Gel Extraction kit. The purified DNA fragment was inserted into pGEM-3Zf(+) vector (Promega), also digested with BamHI and HindIII, using T4 DNA ligase (Roche Applied Sciences). Electroporation-competent Escherichia coli XL1-Blue cells (Stratagene) were transformed with the ligase mixture, and positive clones containing the pGSTA2 sequence were identified by PCR using colony lysate as a template and appropriate primers. The plasmid DNA was isolated from positive clones using a Plasmid Mini kit (Qiagen) and sequenced using a MegaBACE 1000 kit (GE Healthcare) at the Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Construction of the expression plasmid pET-21α(+)-pGSTA2
At first, pGEM-3Zf(+)-pGSTA2 was digested with NdeI and a 722 bp fragment, containing the pGSTA2 sequence, was purified using a QIAquick Gel Extraction kit. Then, this fragment was digested with HindIII yielding a fragment of 676 bp that was ligated into NdeI/HindIII-restricted pET-21α(+) expression vector (Novagen) using T4 DNA ligase. The ligation mixture was used to transform electroporation-competent E. coli XL1-Blue cells, and positive clones containing pGSTA2 sequence were identified by PCR using colony lysate as a template and appropriate primers. The plasmid DNA from positive clones was isolated using a Plasmid Mini kit, and the presence of the target pGSTA2 sequence was verified by the analysis of the size of fragments resulting from restriction of the construct with NdeI and HindIII.
Expression of pGST A2-2 and hGST A3-3 in E. coli
The pET-21α(+)-pGSTA2 plasmid was transformed into electroporation-competent E. coli Rosetta TM (DE3) cells (Novagen). All cultures were grown in the presence of 100 μg/ml ampicillin and 34 μg/ml chloramphenicol at 30
• C in a shaker at 200 rev./min. A starter culture of 100 ml of LB (Luria-Bertani) medium was inoculated with single colonies of freshly transformed cells and incubated for 14 h. Then, 3 litres of 2 × YT (yeast extract/tryptone) medium were inoculated with starter culture at 1:50 and grown for 3 h until the D 600 was 0.6. Then, IPTG (isopropyl β-D-thiogalactopyranoside) (Sigma) was added to a final concentration of 1 mM and incubation was continued for 18 h. The cell culture was chilled on ice and then harvested at 10 000 g for 9 min. The cell pellets were frozen at −20
• C until subsequent protein purification. Likewise, hGST A3-3 was expressed using pET-21α(+)-hGSTA3 plasmid constructed earlier in our laboratory [23] .
Purification of pGST A2-2
The cell pellet from 3 litres of bacterial culture was resuspended in 100 ml of ice-cold lysis buffer [1 mg/ml lysozyme in 0.1 M Tris/HCl (pH 8.0), 0.1 % Triton X-100, 1 mM EDTA, 14 mM 2-mercaptoethanol, 0.1 % polyethyleneimine (Fluka) and Complete TM EDTA-free protease inhibitors (Roche Diagnostics)] and kept on ice for 2 h under stirring. After ultrasonication, the insoluble debris were sedimented by centrifugation at 10 000 g for 45 min. The supernatant was supplemented with (NH 4 ) 2 SO 4 to 50 % saturation at 0
• C, incubated for 1 h on ice, centrifuged at 40 000 g for 45 min, and the pellet was discarded. The supernatant was supplemented further with (NH 4 ) 2 SO 4 to 75 % saturation at 0
• C, incubated for 1 h on ice and centrifuged at 40 000 g for 45 min. The supernatant was discarded and the pellet was dissolved in 8 ml of ice-cold starting buffer [10 mM NaCl, 20 mM sodium phosphate (pH 6.0) and13 mM 2-mercaptoethanol]. The remaining (NH 4 ) 2 SO 4 was removed by repeated gel filtration on PD-10 columns (GE Healthcare) until the conductivity was 3-4 μS/cm, similar to 3 μS/cm of the starting buffer. The solution was loaded on to an SP-Sepharose FF (GE Healthcare) column (3.2 cm internal diameter, 13.7 cm bed height) at 0.8 ml/min. The column was washed with 7 bed volumes of starting buffer at 0.8 ml/min. Protein was eluted from the column by gradient elution over 6 bed volumes at 0.5 ml/min; the ice-cold end buffer contained 210 mM NaCl in 20 mM sodium phosphate (pH 6.0) and 13 mM 2-mercaptoethanol. Fractions of 6 ml were collected, and the protein-containing fractions were analysed for GST activity with CDNB (1-chloro-2,4-dinitrobenzene) under standard conditions as described below. Enzymatically active fractions were pooled (250 ml) and concentrated to 9 ml by ultrafiltration on a polyethersulfone membrane with a 10 kDa molecular-mass cut-off (Pall Life Sciences). The concentrate was transferred to 50 ml of 40 % slurry of S-hexylglutathioneSepharose (prepared from epoxy-activated Sepharose, GE Healthcare) equilibrated with ice-cold binding buffer [10 mM Tris/HCl (pH 8.4) and 5 mM 2-mercaptoethanol], and left on ice for 8 h. After adsorption, the gel was washed batch-wise with 4 × 50 ml of binding buffer supplemented with 0.2 M NaCl, packed into a column (1.9 cm internal diameter), and the bound protein was eluted with 50 mM glycine/NaOH (pH 10) at 1 ml/min. Fractions of 2 ml were collected into tubes already containing 0.2 ml of 2 M Tris/HCl (pH 7.2) in order to lower the pH immediately after elution. The affinity purification was repeated twice, because the gel capacity was exceeded. Proteincontaining fractions were combined, dialysed against 10 mM Tris/HCl (pH 8.4) containing 2 mM DTT (dithiothreitol) at 4
• C, concentrated to 39 mg/ml by ultrafiltration, divided into 43 μl aliquots and stored at −80
• C. Enzyme purity was assessed by SDS/PAGE (12 % gels) applying both optimal and excessive protein amounts to visualize possible impurities. For dialysis, we used regenerated Spectra/Por ® 3 cellulose tubing (Spectrum Labs) with a 3.5 kDa molecular-mass cut-off.
Purification of hGST A3-3
hGST A3-3 was purified with 92 mg of yield from 1 litre of bacterial culture as follows. The cell pellet was resuspended in 50 ml of ice-cold lysis buffer [1 mg/ml lysozyme in 10 mM Tris/HCl (pH 8.4), 0.1 % Triton X-100, 1 mM EDTA, 14 mM 2-mercaptoethanol and Complete TM EDTA-free protease inhibitors] and kept on ice for 2 h under stirring. After ultrasonication, the cell debris were removed by centrifugation at 20 000 g for 45 min followed by filtering through a 0.22 μm Supor ® membrane (Pall Life Sciences). The supernatant was added to 50 ml of 20 % slurry of S-hexylglutathione-Sepharose 6B equilibrated with icecold binding buffer [10 mM Tris/HCl (pH 8.4) and 5 mM 2-mercaptoethanol], and left on ice for 14 h. After adsorption, the gel was washed batch-wise with 6 × 50 ml of binding buffer supplemented with 0.2 M NaCl, packed into a column (1 cm internal diameter) and eluted as described for pGST A2-2. The protein-containing fractions were pooled, concentrated from 50 ml to 5 ml, desalted on PD-10 columns into ice-cold 10 mM Tris/HCl (pH 7.8) containing 5 mM 2-mercaptoethanol, concentrated to 47 mg/ml by ultrafiltration, divided into 20 μl aliquots and stored at −80
Determination of pI and apparent molecular mass
Superdex 200 prep grade was packed in XK16/60 (GE Healthcare) and equilibrated with 10 mM Tris/HCl (pH 7.8) containing 0.2 M NaCl at 4
• C at 0.5 ml/min. The pGST A2-2 apparent molecular mass was determined on the column using an LMW Gel Filtration Calibration kit (GE Healthcare) according to the manufacturer's instructions.
The pI was determined by isoelectric focusing on a pre-cast Ampholine TM PAGplate pH 3.5-9.5 (GE Healthcare) on a 2117 Multiphor II Electrophoresis unit (LKB) at 10
• C using 1500 V, 50 mA and 30 W. An Isoelectric Focusing Calibration kit Broad pI (pH 3-10) (Amersham Biosciences) was used. Staining and pI calculation were performed according to the manufacturer's instructions.
Kinetic characterization and inhibition studies
The reaction rates with various substrates were followed spectrophotometrically (Shimadzu UV-2501PC) with an empty cell as a reference. 5AD and 5PD were purchased from Steraloids, and other substrates were from Sigma-Aldrich. All substrates except for GSH were dissolved in organic solvents, and, in some cases, the enzyme stock solution contained 45 % (w/v) glycerol (AnalaR ® , BDH). The molar absorption coefficients used for calculations were ε 248 (5AD) = 16.3 mM
(Non is trans-non-2-enal), and ε 274 (PEITC) = 8.89 mM
Specific activities were determined at 30
• C under the following conditions: 5AD (0.1 mM) or 5PD (0.01 mM) with 1 mM GSH, in 25 mM Na 2 HPO 4 /HCl (pH 8), 5 % ethanol and 0.9 % glycerol; CDNB (1 mM) with 1 or 5 mM GSH, in 0.1 M KH 2 PO 4 /KOH (pH 6.5) and 2 % ethanol; CHP (1.5 mM) with 1 or 2 mM GSH, in PBS (pH 7.4), 0.3 unit/ml glutathione reductase (Sigma), 0.1 mM NADPH (Sigma), 5 % ethanol and 0.9 % glycerol; EA (0.1 mM) with 0.25 or 2.5 mM, GSH in PBS (pH 7.4) and 1 % methanol; Hex (0.1 mM) with 0.5 mM GSH, in PBS (pH 7.4) and 1 % ethanol; Non (0.1 mM) with 0.5 mM GSH, in PBS (pH 7.4) and 1 % ethanol, alternatively, with 1 mM GSH, in 0.1 M KH 2 PO 4 /KOH (pH 6.5), 5 % ethanol and 0.9 % glycerol; PEITC (0.1 mM) with 1 mM GSH in 0.1 M NaH 2 PO 4 /NaOH (pH 6.5), 2 % methyl cyanide and 0.8 % glycerol.
For determination of steady-state parameters, the MichaelisMenten equation was fitted to reaction rates (Simfit 6.0.28 software, W.G. Bardsley, University of Manchester, Manchester, U.K.) determined with a fixed concentration of GSH and variable concentrations of the second substrate. Saturation curves for steady-state parameter determinations were obtained at 30
• C under the following conditions (all reaction mixtures also contained 0.8-0.9 % glycerol): 5AD (0.001-0.1 or 0.0005-0.1 mM) with 1 mM GSH, in 25 mM Na 2 HPO 4 /HCl (pH 8) and 1 % methanol or 5 % ethanol respectively; 5PD (0.001-0.03 mM) with 1 mM GSH, in 25 mM Na 2 HPO 4 /HCl (pH 8) and 5 % ethanol; CDNB (0.002-1 mM) with 5 mM GSH or 0.001-0.2 mM Non with 1 mM GSH, in 0.1 M KH 2 PO 4 /KOH (pH 6.5) and 5 % ethanol; CHP (0.025-1.5 mM) with 2 mM GSH, in PBS (pH 7.4) and 5 % ethanol; PEITC (0.001-0.1 mM) with 1 mM GSH, in 0.1 M NaH 2 PO 4 /NaOH (pH 6.5) and 2 % methyl cyanide.
Studies of inhibition by tributyltin chloride (Aldrich) were carried out with 5AD and CDNB at 30
• C. For each substrate, five saturation curves were obtained in the presence of 0, 10, 20, 40, 60 and 120 nM inhibitor under the following conditions: 5AD (0.001-0.2 mM) with 1 mM GSH, in 25 mM Na 2 HPO 4 /HCl (pH 8), 5 % ethanol and 0.8 % glycerol; CDNB (0.002-2.5 mM) with 5 mM GSH, in 0.1 M KH 2 PO 4 /KOH (pH 6.5), 5 % ethanol and 0.8 % glycerol. The reaction rates obtained were processed in Prism 5.02 (GraphPad). Eadie-Hofstee plots were examined to verify that the data were described by a simple hyperbolic equation. The Michaelis-Menten equation was fitted to each saturation curve separately. The inhibitor concentration of 120 nM was later excluded from analysis because, owing to an inability to reach saturation within the solubility range of the substrate, parameters could not be determined accurately. Obtained apparent steady-state parameters were plotted against inhibitor concentration in order to determine the inhibition type. Finally, for each substrate-enzyme combination, all reaction rates were fitted simultaneously (global fit in Prism 5.02) to the chosen inhibition model and the parameters were determined.
Expression of pGST A2-2 in various tissues
A PCR was performed using cDNAs from ten tissues of an individual Yorkshire male pig (Zyagen) as a template. Broken boxes outline clusters of different residues in pGST A2-2 in comparison with hGST A3-3. H-site and G-site residues are highlighted by black backgrounds and white backgrounds respectively, whereas residues contributing to both sites are marked with black/white backgrounds. Active-site residues were deduced from the following PDB entries: for hGST A1-1, 1GSF (2.70 Å, where 1 Å = 0.1 nm) and 1PKW (2.00 Å); for hGST A2-2, 2VCT (2.10 Å) and 2WJU (2.30 Å); for hGST A3-3, 2VCV (1.80 Å) and 1TDI (2.4 Å); and for hGST A4-4, 1GUL (2.70 Å). Secondary structure was visualized by the aid of POLYVIEW [48] using respective PDB entries and aligned as hA3-hA1-hA2-hA4 from top to bottom above the amino acid sequences.
Sequence-specific primers for the amplification of full-length pGSTA2 were identical with those used for cloning. For normalization of the data, a 202 bp fragment of porcine β-actin was amplified using primers 5 -TCCTTCCTGGGCATGGAA-3 and 5 -GCGCGATGATCTTGATCTTCATC-3 . The designed primers exclude amplification of non-spliced isoforms of β-actin as well as α-actin. The mixture of 25 μl contained 0.25 μl of template cDNA, 0.2 mM dNTPs, 0.5 μM of each primer and 0.01 unit/μl Phusion DNA polymerase in 1 × Phusion HF buffer. For pGSTA2 amplification, heating for 3 min at 98
• C was followed by 34 cycles of 98
• C for 10 s, 63
• C for 30 s, 72
• C for 20 s and, finally, by an additional step at 72 • C for 5 min. For β-actin amplification, heating at 3 min at 98
• C was followed by 25 cycles of 98
• C for 10 s, 60
• C for 20 s and, finally, by an additional step at 72
• C for 5 min. PCR products were separated on 2 % agarose/TBE (Tris/borate/EDTA) gel, stained with ethidium bromide and a photo was taken. Primer specificity was confirmed by sequencing of PCR fragments from liver and testis. For quantification, the intensity of PCR fragments was evaluated using ImageJ 1.33u software (NIH). Intensities of pGSTA2 PCR fragments were normalized to the intensities of β-actin bands from the corresponding tissues and to the intensity of the pGSTA2 band from liver. The resulting normalized intensity values were assigned to an ordinal scale as follows: (0; 0.1) = +, [0.1; 0.5) = ++, [0.5; 1) = +++.
RESULTS
Choice of pGST potentially active as a steroid isomerase
A BLASTP (SIB BLAST Network service) search restricted to mammals was performed against the UniProtKB using the amino acid sequence of hGST A3-3 (Swiss-Prot accession number Q16772) as a query. Five porcine amino acid sequences were retrieved, Swiss-Prot accession numbers P51781 and P80031 and TrEMBL accession numbers Q29057, Q29581 and Q29188 (Supplementary Figure S1 at http:// www.BiochemJ.org/bj/431/bj4310159add.htm). In the present study, we chose a putative GST, accession number Q29057, for which an mRNA transcript has been identified as involved in pig ovarian follicular differentiation [24] . The sequence was assigned to the Alpha class because of 84 % amino acid identity with hGST A3-3 ( Figure 1 ). In accordance with the latest convention on GST nomenclature [25, 26] , we refer to this enzyme as porcine GST Alpha 2-2 or pGST A2-2. When many organisms are considered, this enzyme should be referred to as SscGST A2-2 where Ssc represents the Sus scrofa species.
Molecular cloning of pGSTA2 cDNA
pGSTA2 cDNA was cloned from ovary as well as from testis. Total RNA was isolated from the tissues, and cDNA was synthesized using anchored oligo(dT) 23 . PCR fragments were amplified using pGSTA2-specific primers and inserted into the pGEM-3Zf(+) cloning vector. pGSTA2 cDNAs cloned from both ovary and testis were sequenced and showed identity with the pGSTA2 sequence published in the database. The pGSTA2 cDNA was successfully subcloned into the pET-21α(+) vector for overexpression in E. coli.
Heterologous expression and purification of pGST A2-2
pGST A2-2 was expressed in the E. coli Rosetta TM (DE3) strain and purified to homogeneity. A purification method involving fractional ammonium sulfate precipitation, SP-Sepharose cation-exchange and S-hexylglutathione affinity chromatographies was developed in order to obtain pGST A2-2 of the purity and quantity necessary for crystallization trials. This three-step purification procedure yielded 150 mg of high-purity pGST A2-2 from 3 litres of culture. Other purification approaches were not as efficient. The widely used glutathione-affinity chromatography yielded only 11.2 mg of the protein from 3 litres of bacterial culture, because the bulk of the overexpressed enzyme did not bind to the chromatography medium, but appeared in the flowthrough. Alternatively, up to 32 mg of the enzyme was obtained from 1 litre of culture using CM-Sepharose. It should also be mentioned that pH 6 as well as very low ionic strength were necessary for complete adsorption of pGST A2-2 to a cation-exchanger (see Supplementary Figure S2 at http://www.BiochemJ.org/bj/431/bj4310159add.htm).
Characterization of basic physical properties and catalytic activities of pGST A2-2
pGST A2-2 contains 223 amino acid residues including the initial methionine. The molecular mass of the pGST A2-2 subunit is 25.4 kDa, but the protein is a dimer with an apparent molecular mass of 40 kDa as determined by gel filtration. The molar absorption coefficient of 18.91 mM −1 · cm −1 and Abs 0.1% of 0.745 at 280 nm, assuming both cysteine residues (Cys 18 and Cys 112 ) are reduced, were calculated by the ProtParam tool and used to determine the enzyme concentration. The pI of 9.15 (10 • C) was determined experimentally by isoelectric focusing. The specific activities of pGST A2-2 with several substrates were measured under standard conditions ( Table 1 ). The enzyme demonstrated the highest specific activity of 53 μmol/min per mg with 5AD and moderate activity with CDNB and PEITC (14 and 13 μmol/min per mg respectively), whereas activities with CHP, 5PD, Non, Hex and EA did not exceed 4.2 μmol/min per mg. Normalizing all values obtained in the presence of 1 mM GSH (or approximated to the presence of 1 mM GSH) to the specific activity with 5AD (100 %), it appears that pGST A2-2 shows 25 % activity with CDNB and PEITC, and less than 4 % activity with CHP, 5PD, Non, Hex and EA.
Steady-state kinetic parameters of pGST A2-2
Steady-state parameters were determined with various substances (Table 2 ) characterized as substrates for pGST A2-2: 5AD, 5PD, CDNB, CHP, Non and PEITC (Figure 2 ). All parameters were measured at the saturating concentration of glutathione of 1-5 mM and no more than 1.5 mM concentration of the variable substrate. The concentration used was limited either by the solubility of the electrophile or the high rate of the non-enzymatic reaction. pGST A2-2 obeyed Michaelis-Menten kinetics under the conditions used. The specificity constant k cat /K m and the Michaelis constant obtained with 5AD, the most active substrate, were approx. 1600 mM −1 · s −1 and 25 μM respectively. 5PD has a lower K m of 9 μM, which points to it as another preferable substrate, even though its catalytic constant is only 1.5 s
. PEITC has a k cat /K m value of 150 mM −1 · s −1 , similar to that of 5PD. The Michaelis constants for the naturally occurring PEITC, Non and both steroids are below 60 μM, whereas the K m values for the artificial substrates CDNB and CHP exceed 300 μM. CHP also has a low k cat of 2.5 s −1 , which, in combination with the K m value, makes it a poor substrate.
Inhibition characteristics of pGST A2-2 and hGST A3-3
Inhibition studies were performed on pGST A2-2 and hGST A3-3 using tributyltin chloride, an inhibitor of steroidogenesis [27] [28] [29] [30] . Both pGST A2-2 and hGST A3-3 were found to be competitively inhibited by tributyltin chloride in reaction with 5AD, since the V max (app) was independent of the inhibitor concentration (see Supplementary Figure S3 at http://www. BiochemJ.org/bj/431/bj4310159add.htm). The inhibition constants obtained with 5AD are 30 nM for pGST A2-2 and 78 nM for hGST A3-3 (Table 3) . Using CDNB as substrate, tributyltin chloride gave rise to increasing K m (app) and decreasing V max (app). The data were best described by the mixed inhibition rather than the non-competitive model since the α coefficients were not equal to 1 for any of the enzymes. For pGST A2-2 and hGST A3-3, K i CDNB was determined as 22 nM and 25 nM respectively (Table 3) .
Tissue expression of pGST A2-2
During the molecular cloning experiment, expression of pGSTA2 mRNA in ovary appeared to be at a level similar to that in testis. The molecular cloning from both ovary and testis was performed in parallel using the same amount of mRNA/cDNA template for final PCR intended for full-length pGSTA2 cDNA amplification. PCR products from the two tissues appeared on an agarose gel as bands with high intensities ( Figure 3A) . To investigate further whether pGST A2-2 is expressed in tissues of major steroid hormone synthesis, the presence of pGSTA2 mRNA was tested in ten porcine tissues ( Figure 3B ) using sequencespecific primers. By sequencing the PCR fragments obtained, we verified that primers did not cross-amplify any similar GST. We also verified that the primers did not amplify another GST by using the very similar pGST A1-1 sequence as a template. The most intensive signals were detected in liver and testis. Pituitary, skin and kidney displayed weak signals. No pGSTA2 mRNA was observed in adipose tissue, adrenal, brain, lung and prostate. Neither in molecular cloning experiments nor in studying the expression profile were tissue or gender polymorphisms detected by sequencing. 5AD is a precursor of sex steroid hormones in both sexes. Its synthesis from pregnenolone requires double-bond steroid isomerization activity that is catalysed by 3β-HSD complemented by hGST A3-3 in humans [19] . Among eutheria, hGST A3-3 has the highest isomerase activity so far discovered. The k cat /K m value for 5AD has been reported as 3600-5000 mM −1 · s −1 [17, 23, 31] . The k cat /K m value for hGST A1-1, the second highest isomerase activity in humans, is significantly lower at 180-980 mM −1 · s −1 [13, 31, 32] . The isomerase activity of pGST A2-2, cloned and characterized in the present study, is intermediate between these values: k cat /K m is 960-2300 mM −1 · s −1 . The major contribution to the differences in activity of hGST A1-1, hGST A3-3, pGST A2-2 as well as bGST (bovine GST) A1-1 [33] is found in the k cat Figure 3 Tissue-specific expression of pGSTA2 (A) Cloning of pGST A2-2 from ovary and testis reveals comparably high amounts of pGSTA2 cDNA. The molecular cloning of pGSTA2 was performed in parallel from ovary and testis. The same amount of mRNA/cDNA template was used for final PCR intended for full-length pGSTA2 cDNA. Similar amounts of pGSTA2 cDNA were obtained from ovary and testis. (B) Full-length pGSTA2 cDNA from ten tissues was amplified using sequence-specific primers. Primers to amplify porcine β-actin were designed to exclude α-actin and non-spliced isoforms of β-actin. Intensity of PCR fragments was evaluated using ImageJ 1.33u software (NIH). For quantification, pGSTA2 PCR fragment intensities were normalized to the respective β-actin band intensities. The resulting intensities were normalized further to pGSTA2 band intensity in liver. values varying >100-fold, whereas K m values differ <10-fold. The catalytic activities with 5PD for these enzymes are lower, but the ranking of the relative activities is the same as with 5AD ( Figure 2) .
Human 3β-HSDs are less catalytically efficient. With 5AD, k cat /K m of human 3β-HSD type 2 and type 1 is 0.6 % and 0.3 % of hGST A3-3 respectively [34, 35] . With 5PD, k cat /K m of human 3β-HSD type 1 is 4 % of hGST A3-3 [35] . Porcine 3β-HSD isomerase activity has not been measured yet. For comparison, (k cat /K m ) 5AD of human 3β-HSD2 does not exceed 2 % of that for pGST A2-2 [34] . In vivo, although, 3β-HSDs have been shown to be the major steroid isomerases presumably due to membrane localization [16] , the contribution of pGST A2-2 to steroidogenesis in vivo has yet to be studied.
Catalytic efficiency profiles reveal pGST A2-2 similarity to hGST A3-3
In order to assess whether pGST A2-2 is a functional analogue of an Alpha class hGST, we compared its steady-state parameters for six substrates representing different types of chemistry (Figure 2) . Although catalytic properties of Alpha class hGSTs have not been compared systematically, many kinetic measurements reported provide insight into the catalytic activity of the enzymes. Owing to low activity with 5AD relative to other substrates, neither hGST A2-2 [13, 36, 37] nor hGST A4-4 [32, 36, 38, 39] can be considered as analogues of pGST A2-2. hGST A5-5 has been poorly characterized so far, and it is not yet clear whether it is expressed in vivo at all [40] . Prominent catalytic efficiencies with 5AD and 5PD position pGST A2-2 substrate preference between those of hGST A1-1 and A3-3 ( Figure 2 ). However, the higher k cat /K m for PEITC over CDNB as well as CHP indicates that pGST A2-2 follows the catalytic efficiency profile of hGST A3-3 rather than hGST A1-1.
Inhibition studies point to a resemblance of pGST A2-2 and hGST A3-3
Tributyltin chloride is a ubiquitous contaminant whose detrimental effects on growth and steroid hormone production have been shown in mice [27] , rats [28] , cattle [29] and pigs [30] . hGST A3-3 and pGST A2-2 showed a decreased activity in the presence of tributyltin chloride. Furthermore, the type of inhibition was shown to be similar between these enzymes (Table 3 ). The inhibition of 5AD isomerization was competitive, whereas the inhibition of CDNB conjugation was of mixed type. Knowing that both 5AD and CDNB bind in the H-site and that CDNB is less bulky than 5AD, it can be assumed that the uncompetitive component appears when the inhibitor binds to the H-site together with CDNB forming a dead-end complex. The larger 5AD molecule may prevent simultaneous binding of the inhibitor. The α CDNB coefficient for pGST A2-2 is half of α CDNB for hGST A3-3 (5 compared with 10), implying that pGST A2-2 H-site accommodates the inhibitor into the GST-GSH-CDNB complex more readily and might be more spacious than that of hGST A3-3. The strength of inhibition was found to be similar for both enzymes, although, in the case of 5AD, the K i of pGST A2-2 is half of that for hGST A3-3, implying that pGST A2-2 is more susceptible than hGST A3-3 to inhibition of the isomerization reaction by tributyltin chloride.
Tissue expression of pGST A2-2 coincides with the steroid biosynthesis profile pGST A2-2 expression was detected in gonads. In combination with high steroid isomerase activity of the enzyme, it strengthens the notion that pGST A2-2 contributes to sex steroid production in vivo. The pGST A2-2 expression pattern apparently shares features of both hGST A1-1 and hGST A3-3. pGST A2-2 mRNA biosynthesis is rather tissue-selective, like that of hGST A3-3 or hGST A1-1/A2-2, whereas hGST A4-4 biosynthesis is ubiquitous [18] . On the other hand, the hGSTA3-3 transcript is subject to alternative splicing [17, 18] , which we did not observe for pGST A2-2. hGST A2-2 expression appears to be less related to steroidogenic tissues than hGST A1-1, being absent from placenta and mammary gland. Otherwise the hGST A2-2 mRNA profile is very similar to hGST A1-1 with expression occurring selectively [18] . In contrast with hGST A3-3, pGST A2-2 was found to be expressed in liver. However, 3β-HSD has also been detected in porcine liver at the mRNA [41] and the protein [42] levels, suggesting that its activity may be complemented by pGST A2-2 in this tissue. Low expression of pGST A2-2 in kidney, skin and pituitary is consonant with low steroid production outside the steroidogenic centres. For example, in humans, 3β-HSD type 1 is expressed in skin, liver and other peripheral tissues [14] [15] [16] . pGST A2-2 expression in liver and kidney may also be interesting due to its considerable PEITC conjugation activity. PEITC has been shown to inhibit the growth of breast [43] and ovarian [44] cancer cells in humans at nutritionally relevant concentrations. The growth inhibition functions via down-regulation of oestrogen receptor α expression, which abrogates mitogenic oestrogen signalling [45] . Therefore contribution to sex steroid production as well as neutralization of PEITC by pGST A2-2 and hGST A3-3 might be important for the development of steroid-dependent cancer cells.
Amino acid sequence comparison reveals clusters of variable residues
pGST A2-2 shares 84 % identical amino acid residues with hGST A3-3 ( Figure 1 ). Amino acid residues differentiating pGST A2-2 from hGST A3-3 are non-uniformly distributed and rather clustered at three regions (dashed boxes on Figure 1 ): seven of ten differences in the N-terminal thioredoxin domain are located within the Glu 36 -Leu 51 region, nine of 15 substitutions in the Cterminal domain range from Pro 113 to Lys 141 , and the terminal 17 residues include eight substitutions. As shown in Figure 1 , those regions of residue variability involve the H-site and, to a lesser extent, the G-site. The first cluster of variable residues spans the α2 helix situated between the β-sheet and the end of the helix α9 on the surface. In Alpha class hGSTs, Arg 45 forms a salt bridge with the C-terminus of GSH. In pGST A2-2, Thr 45 could form the hydrogen bond to Gln 53 , but is out of reach for GSH, which might affect GSH binding. The second cluster of variable residues (including Arg 131 conserved for GSH binding) is located in helix α5 situated on the edge of the second monomer on the other side of the active site at a 90
• angle to helix α9. All variable residues are either on the surface or conservative and do not seem to disturb the arrangement of helices α4 and α5. The third cluster of variable residues includes the terminal helix α9 confining the H-site and contains the only two residues discriminating the H-site of pGST A2-2 from that of hGST A3-3.
Structure-function relationships for isomerase activity
pGST A2-2 shares 84 % sequence identity with hGST A3-3 ( Figure 1 ). However, absolute isomerase activity value or its ratio to other substrates cannot be predicted on the basis of overall identity. For example, the (k cat /K m ) 5AD of hGST A1-1 and hGST A2-2/Penta mutant [36] are 0.5 and 2-fold that of pGST A2-2 respectively (Figure 2) [13, 31, 32] , whereas both share 91 % identity with hGST A3-3.
Steroid bound in the H-site of hGST A3-3 may interact with 17 amino acid residues as deduced from the crystal structures ( Figure 1 ) [31, 46] . For all Alpha GSTs characterized including its mutants (with the only exception being the hGST A3-3/Triple mutant [23] ), increasing the number of differences from the Hsite of hGST A3-3 lowers the catalytic efficiency of the GSTs. All H-site residues of pGST A2-2 except for Thr 208 and Ser 212 are identical with those of hGST A3-3. These residues, which are both alanine in hGST A3-3, surround the 17-carbonyl of 5AD and seem to account for the two-thirds loss in (k cat /K m ) 5AD of pGST A2-2. Bulkier polar side chains directed towards the centre of the steroid-binding cavity could affect both the K m , by decreasing the hydrophobicity of the H-site, and the k cat , by changing the 5AD positioning relative to GSH and Tyr 9 involved in catalysis [23] . It is interesting, however, that in bGST A1-1, where residue 212 is the long and basic lysine, the K m 5AD is the lowest of all steroids and all Alpha GSTs [33] . Also in hGST A4-4 containing Tyr 212 , K m 5AD is no more than that of hGST A1-1 with Ser 212 . The fact that neither lysine nor tyrosine in position 212 abolish 5AD binding may be explained by the hGST A1-1 structure: Ser 212 in hGST A1-1 points outwards from the active site and is exposed to solvent (PDB codes 1GSF and 1PKW). Alanine at position 208 has been identified as preferential over methionine for isomerase activity of hGST A2-2 [36] . As can be concluded from the crystal structures available for hGST A1-1 and A3-3 (PDB codes 2VCV and 1TDI), β-branched Thr 208 of pGST A2-2 could be even less tolerated than Met 208 due to its limited rotational freedom around the Cα-Cβ bond. Isomerase activity of pGST A2-2 is nevertheless higher than that of hGST A1-1.
The polypeptide chain portions in close proximity to bound GSH are highly conserved in Alpha class GSTs. However, G-site residues themselves may vary (Leu 41 and Val 66 in Figure 1 ), indicating that juxtaposition of activated GSH and a steroid substrate in the active site may be disturbed by the overall GST molecule distortion. Conformational plasticity, reported to correlate with high promiscuity of Alpha class GSTs [47] , makes prediction of high isomerase activity in GSTs challenging. (A) For testing the effect of pH on absorption, each of five test tubes was filled with 1 ml of 10 % CM-Sepharose slurry equilibrated with 20 mM sodium phosphate (pH 6.0, 6.5, 7.0, 7.5 or 8.0) and supplemented with 2.5 μl of 8 mg/ml pGST A2-2. All mixtures were agitated gently for 10 min, and the gel was allowed to settle. The GST activity with CDNB was analysed using 20 μl of supernatant in 1 ml of reaction mixture. In the blank reaction, the reaction buffer was used instead of the supernatant. Measurements were performed in triplicate and results are means + − S.D. (B) Testing for the effect of salt concentration was carried out likewise, except that the gel was equilibrated with 20 mM sodium phosphate (pH 6.0) supplemented with various NaCl concentrations.
